drugset / Trial / NCT06133166

A Study for the Treatment of Dry Eye in Postmenopausal Women

NCT06133166 ↗

Phase 2 Unknown 240 enrolled Changchun GeneScience Pharmaceutical Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of EG017 Ointment for the Treatment of Dry Eye in Postmenopausal Women

Timeline

Start
2023-09-20
Primary completion
2024-05-31
Completion
2024-08-09

Drugs

EvaluationDrugModalityDoseRoute
Subject EG017 Unknown 3 % Topical
Subject EG017 Unknown 5 % Topical
Subject EG017 Unknown 9 % Topical

Indications

No indication recorded.